SERGIO A JIMENEZ
Medical Practice in Philadelphia, PA
License number
Pennsylvania MD034713L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Philadelphia, PA 19107
Personal information
See more information about SERGIO A JIMENEZ at radaris.comName
Address
Phone
900 Spruce St #2, Philadelphia, PA 19107
1606 Locust St, Philadelphia, PA 19103
608 Fernon St, Philadelphia, PA 19148
1945 Bridge St, Philadelphia, PA 19124
Organization information
See more information about SERGIO A JIMENEZ at bizstanding.comSergio Jimenez MD
111 S 11 St, Philadelphia, PA 19107
Industry:
Dermatologist, Internist
Phone:
(215) 955-8430 (Phone)
Sergio Astete Jimenez
Professional information
Professor At Thomas Jefferson University
Position:
Professor at Thomas Jefferson University
Location:
Greater Philadelphia Area
Industry:
Research
Work:
Thomas Jefferson University
-
Professor
Dr. Sergio A Jimenez, Philadelphia PA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
233 S 10Th St SUITE 509, Philadelphia 19107
(215) 503-5042 (Phone), (215) 923-4649 (Fax)
THOMAS JEFFERSON UNIVERSITY
233 S 10Th St SUITE 450, Philadelphia 19107
(215) 503-5785 (Phone), (215) 503-5788 (Fax)
JEFFERSON DERMATOLOGY ASSOCIATES
833 Chestnut St SUITE 740, Philadelphia 19107
(215) 955-6680 (Phone), (215) 503-3333 (Fax)
(215) 503-5042 (Phone), (215) 923-4649 (Fax)
THOMAS JEFFERSON UNIVERSITY
233 S 10Th St SUITE 450, Philadelphia 19107
(215) 503-5785 (Phone), (215) 503-5788 (Fax)
JEFFERSON DERMATOLOGY ASSOCIATES
833 Chestnut St SUITE 740, Philadelphia 19107
(215) 955-6680 (Phone), (215) 503-3333 (Fax)
Certifications:
Internal Medicine, 1973
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Education:
Medical School
National Higher University of San Marcos / Academy of Human Medicine
Philadelphia General Hospital
Hosp University Pa
Mayo Grad Sch
National Higher University of San Marcos / Academy of Human Medicine
Philadelphia General Hospital
Hosp University Pa
Mayo Grad Sch
Sergio Jimenez, Philadelphia PA
Work:
Thomas Jefferson University
833 Chestnut St, Philadelphia, PA 19107 Jefferson University Physician
1015 Chestnut St, Philadelphia, PA 19107
833 Chestnut St, Philadelphia, PA 19107 Jefferson University Physician
1015 Chestnut St, Philadelphia, PA 19107
Fibrillin 1 Gene Comprising Duplication Mutation And Compositions And Kits Using The Same
US Patent:
6010694, Jan 4, 2000
Filed:
Jul 26, 1996
Appl. No.:
8/687967
Inventors:
Linda D. Siracusa - Cherry Hill NJ
Sergio A. Jimenez - Philadelphia PA
Sergio A. Jimenez - Philadelphia PA
Assignee:
Thomas Jefferson University - Philadelphia PA
International Classification:
A01N 6300, C07H 2104, C12N 500
US Classification:
424 9321
Abstract:
Human fibroblast cells that comprise a gene construct that comprises a duplication mutated fibrillin 1 gene operably linked to functional regulatory elements and compositions comprising such cells are disclosed. Methods of treating wounds and kits for practicing such methods are disclosed. Transgenic animals comprising a duplication mutated fibrillin 1 gene operably linked to a tissue specific and/or inducible promoter are disclosed. Methods of identifying individuals with a duplication mutated fibrillin 1 gene are disclosed. The methods comprises detecting a duplication of exons 17-40 of a fibrillin 1 gene or a gene product produced by expression of a duplication mutated fibrillin 1 gene. Methods of preventing expression of a duplication mutated fibrillin 1 gene are disclosed.
Biomarkers For Early Diagnosis Of Systemic Tissue Fibrosis
US Patent:
2012001, Jan 19, 2012
Filed:
Jul 18, 2011
Appl. No.:
13/184697
Inventors:
Francesco Del Galdo - Leeds, GB
Sergio A. Jimenez - Philadelphia PA, US
Sergio A. Jimenez - Philadelphia PA, US
Assignee:
THOMAS JEFFERSON UNIVERSITY - Philadelphia PA
International Classification:
C12Q 1/68, C12M 1/34, G01N 30/96, G01N 33/566, G01N 33/573
US Classification:
435 612, 436501, 435 74, 422 69, 4352872, 422430
Abstract:
Embodiments of the invention provides methods, devices and kits for determining the likelihood of an individual having an active fibrotic condition and/or early diagnosis, and subsequently prognosis evaluation of an individual having an active fibrotic condition such as systemic sclerosis (SSc) and/or nephrogenic systemic fibrosis (NSF) by measuring the levels of several biomarkers: α-enolase (ENO1), reticulocalbin 3 (RCN-3), alpha smooth muscle actin (α-SMA), reticulocalbin 1 (RCN-1) and pigment epithelium-derived factor (PEDF) in the individual.